Patents by Inventor Christine Parmenter

Christine Parmenter has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods for making definitive endoderm using at least GDF-8
    Patent number: 10351820
    Abstract: The present invention is directed to methods to differentiate pluripotent stem cells. In particular, the present invention is directed to methods and compositions to differentiate pluripotent stem cells into cells expressing markers characteristic of the definitive endoderm lineage comprising culturing the pluripotent stem cells in medium comprising a sufficient amount of GDF-8 to cause the differentiation of the pluripotent stem cells into cells expressing markers characteristic of the definitive endoderm lineage.
    Type: Grant
    Filed: March 13, 2017
    Date of Patent: July 16, 2019
    Assignee: Janssen Biotech, Inc.
    Inventors: Janet Davis, Jiajian Liu, Christine Parmenter, Pascal Ghislain Andre Bonnet
  • Differentiation of pluripotent stem cells
    Patent number: 10233421
    Abstract: The present invention is directed to methods to differentiate pluripotent stem cells. In particular, the present invention is directed to methods and compositions to differentiate pluripotent stem cells into cells expressing markers characteristic of the definitive endoderm lineage comprising culturing the pluripotent stem cells in medium comprising a sufficient amount of GDF-8 to cause the differentiation of the pluripotent stem cells into cells expressing markers characteristic of the definitive endoderm lineage.
    Type: Grant
    Filed: March 13, 2017
    Date of Patent: March 19, 2019
    Assignee: Janssen Biotech, Inc.
    Inventors: Janet Davis, Jiajian Liu, Christine Parmenter, Pascal Ghislain Andre Bonnet
  • DIFFERENTIATION OF PLURIPOTENT STEM CELLS
    Publication number: 20170183625
    Abstract: The present invention is directed to methods to differentiate pluripotent stem cells. In particular, the present invention is directed to methods and compositions to differentiate pluripotent stem cells into cells expressing markers characteristic of the definitive endoderm lineage comprising culturing the pluripotent stem cells in medium comprising a sufficient amount of GDF-8 to cause the differentiation of the pluripotent stem cells into cells expressing markers characteristic of the definitive endoderm lineage.
    Type: Application
    Filed: March 13, 2017
    Publication date: June 29, 2017
    Applicant: Janssen Biotech, Inc.
    Inventors: Janet Davis, Jiajian Liu, Christine Parmenter, Pascal Ghislain Andre Bonnet
  • DIFFERENTIATION OF PLURIPOTENT STEM CELLS
    Publication number: 20170183624
    Abstract: The present invention is directed to methods to differentiate pluripotent stem cells. In particular, the present invention is directed to methods and compositions to differentiate pluripotent stem cells into cells expressing markers characteristic of the definitive endoderm lineage comprising culturing the pluripotent stem cells in medium comprising a sufficient amount of GDF-8 to cause the differentiation of the pluripotent stem cells into cells expressing markers characteristic of the definitive endoderm lineage.
    Type: Application
    Filed: March 13, 2017
    Publication date: June 29, 2017
    Applicant: Janssen Biotech, Inc.
    Inventors: Janet Davis, Jiajian Liu, Christine Parmenter, Pascal Ghislain Andre Bonnet
  • Differentiation of pluripotent stem cells
    Patent number: 9593305
    Abstract: The present invention is directed to methods to differentiate pluripotent stem cells. In particular, the present invention is directed to methods and compositions to differentiate pluripotent stem cells into cells expressing markers characteristic of the definitive endoderm lineage comprising culturing the pluripotent stem cells in medium comprising a sufficient amount of GDF-8 to cause the differentiation of the pluripotent stem cells into cells expressing markers characteristic of the definitive endoderm lineage.
    Type: Grant
    Filed: March 29, 2012
    Date of Patent: March 14, 2017
    Assignee: Janssen Biotech, Inc.
    Inventors: Janet Davis, Jiajian Liu, Christine Parmenter, Pascal Ghislain André Bonnet
  • Differentiation of pluripotent stem cells
    Patent number: 9593306
    Abstract: The present invention is directed to methods to differentiate pluripotent stem cells. In particular, the present invention is directed to methods and compositions to differentiate pluripotent stem cells into cells expressing markers characteristic of the definitive endoderm lineage comprising culturing the pluripotent stem cells in medium comprising a sufficient amount of GDF-8 to cause the differentiation of the pluripotent stem cells into cells expressing markers characteristic of the definitive endoderm lineage.
    Type: Grant
    Filed: March 29, 2012
    Date of Patent: March 14, 2017
    Assignee: Janssen Biotech, Inc.
    Inventors: Janet Davis, Jiajian Liu, Christine Parmenter, Pascal Ghislain André Bonnet
  • Differentiation of human embryonic stem cells
    Patent number: 9133439
    Abstract: The present invention provides methods to promote the differentiation of pluripotent stem cells into insulin producing cells. In particular, the present invention provides a method to increase the expression of NGN3 and NKX6.1 in populations of cells expressing markers characteristic of the pancreatic endocrine lineage.
    Type: Grant
    Filed: December 16, 2010
    Date of Patent: September 15, 2015
    Assignee: Janssen Biotech, Inc.
    Inventors: Janet Davis, Christine Parmenter, Kevin Ditolvo
  • Differentiation of Pluripotent Stem Cells
    Publication number: 20120196365
    Abstract: The present invention is directed to methods to differentiate pluripotent stem cells. In particular, the present invention is directed to methods and compositions to differentiate pluripotent stem cells into cells expressing markers characteristic of the definitive endoderm lineage comprising culturing the pluripotent stem cells in medium comprising a sufficient amount of GDF-8 to cause the differentiation of the pluripotent stem cells into cells expressing markers characteristic of the definitive endoderm lineage.
    Type: Application
    Filed: March 29, 2012
    Publication date: August 2, 2012
    Inventors: Janet Davis, Jiajian Liu, Christine Parmenter, Pascal Ghislain Andrè Bonnet
  • Differentiation of Pluripotent Stem Cells
    Publication number: 20120190111
    Abstract: The present invention is directed to methods to differentiate pluripotent stem cells. In particular, the present invention is directed to methods and compositions to differentiate pluripotent stem cells into cells expressing markers characteristic of the definitive endoderm lineage comprising culturing the pluripotent stem cells in medium comprising a sufficient amount of GDF-8 to cause the differentiation of the pluripotent stem cells into cells expressing markers characteristic of the definitive endoderm lineage.
    Type: Application
    Filed: March 29, 2012
    Publication date: July 26, 2012
    Inventors: Janet Davis, Jiajian Liu, Christine Parmenter, Pascal Ghislain André Bonnet
  • Differentiation of Pluripotent Stem Cells
    Publication number: 20120190112
    Abstract: The present invention is directed to methods to differentiate pluripotent stem cells. In particular, the present invention is directed to methods and compositions to differentiate pluripotent stem cells into cells expressing markers characteristic of the definitive endoderm lineage comprising culturing the pluripotent stem cells in medium comprising a sufficient amount of GDF-8 to cause the differentiation of the pluripotent stem cells into cells expressing markers characteristic of the definitive endoderm lineage.
    Type: Application
    Filed: March 29, 2012
    Publication date: July 26, 2012
    Inventors: Janet Davis, Jiajian Liu, Christine Parmenter, Pascal Ghislain André Bonnet
  • DIFFERENTIATION OF HUMAN EMBRYONIC STEM CELLS
    Publication number: 20110151561
    Abstract: The present invention provides methods to promote the differentiation of pluripotent stem cells into insulin producing cells. In particular, the present invention provides a method to increase the expression of NGN3 and NKX6.1 in populations of cells expressing markers characteristic of the pancreatic endocrine lineage.
    Type: Application
    Filed: December 16, 2010
    Publication date: June 23, 2011
    Inventors: JANET DAVIS, CHRISTINE PARMENTER, KEVIN DITOLVO
  • Differentiation of Pluripotent Stem Cells
    Publication number: 20100015711
    Abstract: The present invention is directed to methods to differentiate pluripotent stem cells. In particular, the present invention is directed to methods and compositions to differentiate pluripotent stem cells into cells expressing markers characteristic of the definitive endoderm lineage comprising culturing the pluripotent stem cells in medium comprising a sufficient amount of GDF-8 to cause the differentiation of the pluripotent stem cells into cells expressing markers characteristic of the definitive endoderm lineage.
    Type: Application
    Filed: June 30, 2009
    Publication date: January 21, 2010
    Inventors: Janet Davis, Jiajian Liu, Christine Parmenter, Pascal Ghislain André Bonnet